Arca
Skip to content
Tools
Tools

WOUNDCHEK Bacterial Status

Assay For Detection Of Proteases In Chronic Wounds. De Novo DEN180014, from Alere Scarborough, Inc. (Scarborough, ME). Product code QFA, class 2.

As of Nov 21, 2026, DEN180014 is an FDA De Novo held by Alere Scarborough, Inc., granted on Dec 2, 2019 after 619 days, with no recalls tied to it in FDA's recall database.

  • Review time: 619 days
  • Recalls: 0

Pivotal study

The main clinical evidence FDA relied on, as its decision summary describes it
Design
Blinded, prospective, multicenter observational study compared to clinical wound healing status
Enrolled
350
Where
7 sites, US
Primary endpoint
Likelihood ratios (PLR, NLR) of WCBS result for risk of non-healing in intended use population (wounds <6 months or <1 cm2)
Result
PLR 2.06 (95% CI 1.25-3.41); NLR 0.69 (95% CI 0.54-0.88) in 147 evaluable wounds

Record

Type
Direct
Received
Mar 23, 2018
Review panel
Microbiology
Regulation
21 CFR 866.3231

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.